首页> 外文会议>Laser Florence congresses >PDT: Special cases in front of legal regulations
【24h】

PDT: Special cases in front of legal regulations

机译:PDT:法律规定面前的特殊案例

获取原文

摘要

Introduction: The classic indication for photodynamic therapy (PDT) in ophthalmology is currently represented by classic subfoveal choroidal neovascularisation (CNV) due to age-related macular degeneration (AMD). PDT is a method, which almost selectively causes endothelial damage in neovascular lesions, followed by vascular occlusion and involution of the CNV. The mechanistic aspect suggests that non AMD-related choroidal neovascularisations might also benefit from PDT. PDT in AMD: Within the German health system, PDT indications follow the criteria based on the inclusion criteria of the TAP studies. For instance the CNV should be predominantly classic and located under the center of the foveal avascular zone. In the diagnosis and follow-up of exudative AMD, visual acuity measurements and fluorescein angiography are the established parameters. Retinal thickness analyzer (RTA) measurements might give further information. Before PDT, they show a significant retinal thickening due to intra- and subretinal exudation. Following PDT, early RTA follow-ups show a clear decrease in retinal thickening accompanied by increasing or stable visual acuity. PDT in CNV of other origins than AMD: New studies support a new spectrum of indications for PDT, hopefully leading to general cost reimbursement for patients. PDT should be viewed as a general method for vascular occlusion and does not represent a causal therapy for progressive exudative AMD. We present patients with CNV due to pathologic myopia, angioid streaks and POHS. Conclusion: The selective vascular occlusion caused by PDT, besides CNV associated with AMD and pathologic myopia, may also allow the treatment of choroidal neovascularisations based on other entities. Careful individual evaluation of those cases is recommended. Despite this wide array of possible indications, cost reimbursement has been limited to classic subfoveal CNV in AMD, although single case reimbursements in choroidal neovascular lesions due to pathologic myopia have been observed.
机译:引言:由于年龄相关的黄斑变性(AMD),目前眼科的光动力治疗(PDT)的视觉疗法(PDT)的经典指示目前代表着经典的子卵形脉络膜新生血管和(CNV)。 PDT是一种方法,其几乎选择性地导致新生血管病变中内皮损伤,然后是血管闭塞和CNV的涉及。机械方面表明非AMD相关的脉络膜新生血管或可能受益于PDT。 PDT在AMD:在德国卫生系统中,PDT适应症根据普及研究的纳入标准遵循标准。例如,CNV应主要是经典的,并且位于心脏缺血区的中心。在渗出和随访的渗透性AMD,视力测量和荧光素血管造影是已建立的参数。视网膜厚度分析仪(RTA)测量可能提供更多信息。在PDT之前,它们由于内部和底序而显着的视网膜增厚。在PDT之后,早期的RTA随访显示视网膜增厚的明显减少,伴随着增加或稳定的视力。 PDT在其他来源的CNV比AMD:新的研究支持新的PDT频谱,希望导致患者一般成本报销。 PDT应被视为血管闭塞的一般方法,并不代表进步渗出的AMD的因果疗法。由于病理近视,血管基肌条纹和POHs,我们将患有CNV的患者呈现CNV。结论:除了与AMD和病理近视相关的CNV外,PDT引起的选择性血管闭塞也可允许基于其他实体治疗脉络膜新生血管。建议仔细个人评估这些案件。尽管存在这种广泛的可能迹象,但成本报销一直仅限于AMD中的经典子流动CNV,尽管已经观察到由于病理近视引起的脉络膜新血管病变的单一案例报销。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号